Sharps Technology (NASDAQ:STSS – Get Free Report) and TREES (OTCMKTS:CANN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.
Volatility and Risk
Sharps Technology has a beta of 2.08, suggesting that its share price is 108% more volatile than the S&P 500. Comparatively, TREES has a beta of -0.48, suggesting that its share price is 148% less volatile than the S&P 500.
Valuation and Earnings
This table compares Sharps Technology and TREES”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sharps Technology | $200,000.00 | 218.95 | -$9.30 million | ($831.83) | 0.00 |
| TREES | $13.66 million | 0.22 | -$3.48 million | ($0.02) | -1.32 |
TREES has higher revenue and earnings than Sharps Technology. TREES is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of current recommendations and price targets for Sharps Technology and TREES, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sharps Technology | 1 | 0 | 0 | 0 | 1.00 |
| TREES | 0 | 0 | 0 | 0 | 0.00 |
Profitability
This table compares Sharps Technology and TREES’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sharps Technology | N/A | -84.26% | -79.52% |
| TREES | N/A | N/A | N/A |
Insider and Institutional Ownership
17.2% of Sharps Technology shares are owned by institutional investors. Comparatively, 11.3% of TREES shares are owned by institutional investors. 1.2% of Sharps Technology shares are owned by insiders. Comparatively, 45.0% of TREES shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
TREES beats Sharps Technology on 6 of the 11 factors compared between the two stocks.
About Sharps Technology
Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
About TREES
Trees Corporation provides products and services to the regulated cannabis industry in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and retail dispensary store in Englewood, Colorado, as well as retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Lakewood, Colorado.
Receive News & Ratings for Sharps Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Technology and related companies with MarketBeat.com's FREE daily email newsletter.
